GlassScriptPhysician profile
Stephanie A Castle
NPI 1679887962
$5,629.97
in general payments reported to CMS, 2019-2025
15 companies · $1,139 in 2025
The $1,139 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2020: $165 · 2021: $1,242 · 2022: $1,089 · 2023: $777 · 2024: $899 · 2025: $1,139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,740 · Entertainment: $75.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,740.16 |
| Entertainment | $75.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,431.84 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Johnson & Johnson Surgical Vision, INC. | $1,118.81 | 2022-2025 | Lipiflow System Activator (Disposable) |
| Bausch & Lomb Americas INC. | $1,058.16 | 2022-2025 | Infuse, Biotrue One Day, Btod |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $540.62 | 2019-2021 | |
| Alcon Vision LLC | $511.30 | 2021-2025 | Dailies Total1, Precision7, Total30 |
| Abb Con-Cise Optical Group LLC | $233.53 | 2019-2023 | Contact Lens, Spectacle Lenses |
| Carl Zeiss Meditec USA, INC. | $205.84 | 2021-2023 | Forum |
| Tarsus Pharmaceuticals, INC. | $200.64 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $87.87 | 2025 | |
| Optos, INC. | $75.40 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Carl Zeiss Meditec, INC. | $71.12 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $42.65 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $18.83 | 2023 | |
| Lombart Brothers, INC. | $17.26 | 2022 | |
| Biotissue Holdings INC. | $16.10 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Castle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.